This company listing is no longer active
Cano Health Management
Management criteria checks 1/4
Cano Health's CEO is Mark Kent, appointed in Jun 2023, has a tenure of less than a year. total yearly compensation is $3.53M, comprised of 8.9% salary and 91.1% bonuses, including company stock and options. directly owns 1% of the company’s shares, worth $12.90K. The average tenure of the management team and the board of directors is 0.9 years and 3 years respectively.
Key information
Mark Kent
Chief executive officer
US$3.5m
Total compensation
| CEO salary percentage | 8.9% |
| CEO tenure | less than a year |
| CEO ownership | 1.0% |
| Management average tenure | less than a year |
| Board average tenure | 3yrs |
Recent management updates
Recent updates
Cano Health: Common Shareholders Likely To Be Wiped Out In Bankruptcy
Feb 06Cano Health: Bankruptcy Likely After Dismal Q2 Results And Debt Covenant Violations
Aug 11Cano Health: CEO Departure Could Be Constructive, New Skipper More So
Jun 20Cano Health: Key Shareholder Meeting Looms, Stock Undervalued But Volatile
Jun 09Analyst Estimates: Here's What Brokers Think Of Cano Health, Inc. (NYSE:CANO) After Its First-Quarter Report
May 12
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$982m |
| Dec 31 2023 | US$4m | US$313k | -US$594m |
Compensation vs Market: Mark's total compensation ($USD3.53M) is above average for companies of similar size in the US market ($USD680.27K).
Compensation vs Earnings: Insufficient data to compare Mark's compensation with company performance.
CEO
Mark Kent (56 yo)
less than a year
Tenure
US$3,529,836
Compensation
Mr. Mark Kent is Chief Executive Officer and Director of Cano Health, LLC from August 2023. He was Interim Chief Executive Officer of Cano Health, LLC from June 2023 to August 2023. He serves as Chief Exec...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$3.53m | 1.0% $ 12.9k | |
| CFO & Chief Accounting Officer | less than a year | US$969.03k | 0% $ 0 | |
| Chief Operating Officer | 1.8yrs | US$1.70m | 5.1% $ 65.9k | |
| Chief Compliance Officer & General Counsel | no data | US$1.03m | 0.18% $ 2.3k | |
| Chief People Officer | 7.4yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Deputy General Counsel & Corporate Secretary | less than a year | no data | no data |
0.9yrs
Average Tenure
57.5yo
Average Age
Experienced Management: CANO.Q's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$3.53m | 1.0% $ 12.9k | |
| Independent Director | 3yrs | US$243.02k | 0.013% $ 171.8 | |
| Non-Executive Chairman & Lead Independent Director | 3yrs | US$278.02k | 2.97% $ 38.4k | |
| Independent Director | 3yrs | US$243.02k | 1.53% $ 19.7k | |
| Independent Director | 3yrs | US$243.02k | 0.013% $ 171.8 | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data |
3.0yrs
Average Tenure
60yo
Average Age
Experienced Board: CANO.Q's board of directors are considered experienced (3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/06/30 05:35 |
| End of Day Share Price | 2024/06/28 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cano Health, Inc. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Adam Ron | BofA Global Research |
| Jason Cassorla | Citigroup Inc |
| Albert J. Rice | Credit Suisse |